Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Year of publication

10 facets displayed. 0 facets selected.

Geography

2 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (22)

All (22) (0 to 10 of 22 results)

  • Articles and reports: 88F0006X2011001
    Description:

    This working paper profiles Canadian firms involved in the development and production of Bioproducts. It provides data on the number and types of Bioproducts firms in 2009, covering bioproducts revenues, research and development, use of biomass, patents, products, business practices and the impact of government regulations on the sector.

    Release date: 2011-12-23

  • Stats in brief: 88-001-X200800110603
    Description:

    Canada's economic competitiveness depends on scientific and technological development and also on the people responsible for this development, especially those engaged in R&D. In an earlier Science statistics bulletin, we published the gross domestic expenditures on R&D in Canada (GERD). This issue presents a supplementary measure to the GERD, the number of personnel who perform Canada's R&D activities.

    Release date: 2008-05-06

  • Stats in brief: 88-001-X20070029607
    Geography: Canada
    Description:

    This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1989 to 2006 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD) are growing.

    Release date: 2007-03-30

  • Stats in brief: 88-001-X20070019573
    Geography: Canada
    Description:

    Canada's economic competitiveness depends on scientific and technological development and also on the people responsible for this development, especially those engaged in R&D. In an earlier Science statistics bulletin, we published the gross domestic expenditures on R&D in Canada (GERD). This issue presents a supplementary measure to the GERD, the number of personnel who perform Canada's R&D activities.

    Release date: 2007-01-16

  • Articles and reports: 88F0006X2006012
    Description:

    This document presents the geographical distribution of federal government expenditures and staff for the fiscal year 2004/2005.

    Release date: 2006-12-22

  • Stats in brief: 88-001-X20060099563
    Description:

    This service bulletin presents the geographic distribution of federal government science and technology expenditures. Data on federal government expenditures on science and technology are found in Volume 30, No. 6 of this publication series, released in September 2006. Science and technology (S&T) expenditures are the sum of expenditures on research and development (R&D) and on related scientific activities (RSA).

    Release date: 2006-12-15

  • Articles and reports: 11F0027M2006040
    Geography: Canada
    Description:

    The paper outlines key conceptual and operational issues involved in capitalizing R&D expenditures in the Canadian System of National Accounts (CSNA), shows statistical estimates by industry for reference year 2000, and assesses the impact of capitalization on main CSNA aggregates.

    Release date: 2006-06-29

  • Stats in brief: 88-001-X20060039191
    Description:

    This service bulletin contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1988 to 2005 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD), are growing.

    Release date: 2006-05-12

  • Articles and reports: 88-003-X20050038761
    Geography: Canada
    Description:

    For many organizations involved in economic development, business incubation is a key to creating and nurturing new business. There is currently very little information available on the business incubator sector in Canada. A new Statistics Canada pilot survey will collect and benchmark vital information on this largely unknown sector of the Canadian economy.

    Release date: 2005-10-26

  • Articles and reports: 88-003-X20050038769
    Geography: Canada
    Description:

    In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.

    Release date: 2005-10-26
Data (1)

Data (1) ((1 result))

  • Table: 88-524-X
    Description:

    The tables provide information on the innovation in the business unit; business unit success factors; new or significantly improved products and processes; unfinished or abandoned innovation activities; innovation activities; sources of information for innovation; co-operative and collaborative arrangements for innovation; obstacles to innovation; impact of innovation; protection of intellectual property and government support programs. The CD provides 1,134 statistical tables based on the Survey of Innovation 2003. The estimates are presented on a national and provincial/territorial level by selected service industries.

    Release date: 2005-01-26
Analysis (21)

Analysis (21) (0 to 10 of 21 results)

  • Articles and reports: 88F0006X2011001
    Description:

    This working paper profiles Canadian firms involved in the development and production of Bioproducts. It provides data on the number and types of Bioproducts firms in 2009, covering bioproducts revenues, research and development, use of biomass, patents, products, business practices and the impact of government regulations on the sector.

    Release date: 2011-12-23

  • Stats in brief: 88-001-X200800110603
    Description:

    Canada's economic competitiveness depends on scientific and technological development and also on the people responsible for this development, especially those engaged in R&D. In an earlier Science statistics bulletin, we published the gross domestic expenditures on R&D in Canada (GERD). This issue presents a supplementary measure to the GERD, the number of personnel who perform Canada's R&D activities.

    Release date: 2008-05-06

  • Stats in brief: 88-001-X20070029607
    Geography: Canada
    Description:

    This release contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1989 to 2006 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD) are growing.

    Release date: 2007-03-30

  • Stats in brief: 88-001-X20070019573
    Geography: Canada
    Description:

    Canada's economic competitiveness depends on scientific and technological development and also on the people responsible for this development, especially those engaged in R&D. In an earlier Science statistics bulletin, we published the gross domestic expenditures on R&D in Canada (GERD). This issue presents a supplementary measure to the GERD, the number of personnel who perform Canada's R&D activities.

    Release date: 2007-01-16

  • Articles and reports: 88F0006X2006012
    Description:

    This document presents the geographical distribution of federal government expenditures and staff for the fiscal year 2004/2005.

    Release date: 2006-12-22

  • Stats in brief: 88-001-X20060099563
    Description:

    This service bulletin presents the geographic distribution of federal government science and technology expenditures. Data on federal government expenditures on science and technology are found in Volume 30, No. 6 of this publication series, released in September 2006. Science and technology (S&T) expenditures are the sum of expenditures on research and development (R&D) and on related scientific activities (RSA).

    Release date: 2006-12-15

  • Articles and reports: 11F0027M2006040
    Geography: Canada
    Description:

    The paper outlines key conceptual and operational issues involved in capitalizing R&D expenditures in the Canadian System of National Accounts (CSNA), shows statistical estimates by industry for reference year 2000, and assesses the impact of capitalization on main CSNA aggregates.

    Release date: 2006-06-29

  • Stats in brief: 88-001-X20060039191
    Description:

    This service bulletin contains estimates of total spending on research and development (R&D) in the health field in Canada. Tables demonstrate expenditures on health R&D by both performer and funder from 1988 to 2005 preliminary estimates. Historical data indicates that in Canada, health R&D expenditures as a percentage of Gross Domestic Expenditures on Research and Development (GERD), are growing.

    Release date: 2006-05-12

  • Articles and reports: 88-003-X20050038761
    Geography: Canada
    Description:

    For many organizations involved in economic development, business incubation is a key to creating and nurturing new business. There is currently very little information available on the business incubator sector in Canada. A new Statistics Canada pilot survey will collect and benchmark vital information on this largely unknown sector of the Canadian economy.

    Release date: 2005-10-26

  • Articles and reports: 88-003-X20050038769
    Geography: Canada
    Description:

    In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.

    Release date: 2005-10-26
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: